Weekly Recap | Humacyte -6.95%, consensus target above spotWeekly Review·Sep 5, 2026 at 07:04 AMHUMA+29.61%
The Nasdaq Biotechnology Index fell by more than 1.2%. Among them, Medpace dropped 15.90%, Tectonic Therapeutic fell 15.22%, Regenxbio decreased 14.31%, Humacyte declined 13.93%, and Anavex Life Sciences fell 8.74%. In contrast, Mesoblast rose 7.21%, Personalis increased 10.03%, Invivyd gained 10.14%, PepGen surged 17.99%, and Neumora Therapeutics jumped 25.10%Wallstreetcn·Feb 10, 2026 at 11:10 PMIDNA-2.39%RGNX-4.71%
